Cargando…
0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects
PURPOSE: To compare the preservative-free corticosteroid 0.2% betamethasone sodium phosphate BID (SURF-201) to vehicle BID in patients undergoing routine cataract surgery. METHODS: Phase 2, multicenter, randomized (1:1 ratio), double-masked, vehicle-controlled, parallel-group study in patients sched...
Autores principales: | Hosseini, Kamran, Gollamudi, Subba, Reiser, Harvey, Walters, Tom, Lindstrom, Richard L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411451/ https://www.ncbi.nlm.nih.gov/pubmed/37564159 http://dx.doi.org/10.2147/OPTH.S419857 |
Ejemplares similares
-
A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects
por: Hosseini, Kamran, et al.
Publicado: (2016) -
Annoying Hiccups following Intra-Articular Corticosteroid Injection of Betamethasone Acetate/Betamethasone Sodium Phosphate at the Knee Joint
por: Habib, George, et al.
Publicado: (2013) -
A Comparative Study of the Respiratory Neonatal Outcomes Utilizing Dexamethasone Sodium Phosphate versus a Mixture of Betamethasone Dipropionate and Betamethasone Sodium Phosphate as an Antenatal Corticosteroid Therapy
por: Altal, Omar F, et al.
Publicado: (2021) -
Autologous Red Blood Cell Delivery of Betamethasone Phosphate Sodium for Long Anti-Inflammation
por: Zhang, Xiumei, et al.
Publicado: (2018) -
Predicting the necessity of LASIK enhancement after cataract surgery in patients with multifocal IOL implantation
por: Gunvant, Pinakin, et al.
Publicado: (2011)